Skip to site menu Skip to page content
Logo Image
In Brief
Spotlight

FDA issues warning to Novo Nordisk on unreported semaglutide safety events

In the warning letter, the FDA alleged that Novo inadequately responded to observations made after an inspection carried out across January and February of 2025.

Latest news

BioNTech co-founders step down to launch new mRNA venture

The leadership changes arrive as BioNTech reported a 57% rise in net losses for 2025.

Eli Lilly to invest $3bn in China in anticipation of orforglipron approval  

The investment in China follows similar outlays by the drugmaker in other regions as it prepares for high orforglipron demand.

Curatis and Neupharma sign development agreement for corticorelin in Japan

Neupharma will fund and conduct a pivotal clinical trial in Japan to support regulatory approval.

Bavarian Nordic and SII sign agreement for chikungunya vaccine production

The new arrangement builds upon the existing mpox vaccine licence and manufacturing partnership between the two companies.

Tariffs, uncertainty and disruption: how drug makers and distributors can build operational supply chain resilience

Ryan Rotar, vice president of healthcare market strategy at Tecsys, outlines how supply chain resilience can be maintained in the face of tariffs.